Group One Trading’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,500
| Closed | -$18.5K | – | 8226 |
|
|
2025
Q3 | $18.5K | Buy |
1,500
+800
| +114% | +$9.38K | ﹤0.01% | 6754 |
|
|
2025
Q2 | $8.06K | Buy |
700
+200
| +40% | +$2.37K | ﹤0.01% | 6845 |
|
|
2025
Q1 | $7.5K | Buy |
500
+100
| +25% | +$1.67K | ﹤0.01% | 6436 |
|
|
2024
Q4 | $6.92K | Buy |
400
+300
| +300% | +$5.79K | ﹤0.01% | 6275 |
|
|
2024
Q3 | $1.85K | Hold |
100
| – | – | ﹤0.01% | 6168 |
|
|
2024
Q2 | $2.03K | Sell |
100
-101,100
| -100% | -$1.79M | ﹤0.01% | 6223 |
|
|
2024
Q1 | $1.73M | Buy |
101,200
+400
| +0.4% | +$6.29K | 0.01% | 1605 |
|
|
2023
Q4 | $1.78M | Buy |
100,800
+98,500
| +4,283% | +$1.98M | ﹤0.01% | 1972 |
|
|
2023
Q3 | $55.2K | Sell |
2,300
-2,700
| -54% | -$66.3K | ﹤0.01% | 5002 |
|
|
2023
Q2 | $116K | Sell |
5,000
-3,400
| -40% | -$76.9K | ﹤0.01% | 4469 |
|
|
2023
Q1 | $185K | Buy |
8,400
+5,900
| +236% | +$138K | ﹤0.01% | 3749 |
|
|
2022
Q4 | $50.7K | Buy |
2,500
+2,200
| +733% | +$42.6K | ﹤0.01% | 4980 |
|
|
2022
Q3 | $4K | Sell |
300
-1,100
| -79% | -$18.5K | ﹤0.01% | 6899 |
|
|
2022
Q2 | $28K | Sell |
1,400
-7,300
| -84% | -$194K | ﹤0.01% | 6026 |
|
|
2022
Q1 | $275K | Buy |
8,700
+4,200
| +93% | +$118K | ﹤0.01% | 4463 |
|
|
2021
Q4 | $100K | Buy |
4,500
+3,400
| +309% | +$88.7K | ﹤0.01% | 5722 |
|
|
2021
Q3 | $31K | Sell |
1,100
-1,600
| -59% | -$48.7K | ﹤0.01% | 6896 |
|
|
2021
Q2 | $105K | Buy |
2,700
+400
| +17% | +$14.3K | ﹤0.01% | 5897 |
|
|
2021
Q1 | $66K | Buy |
2,300
+700
| +44% | +$23.9K | ﹤0.01% | 6016 |
|
|
2020
Q4 | $42K | Buy |
1,600
+900
| +129% | +$18.4K | ﹤0.01% | 5118 |
|
|
2020
Q3 | $11K | Sell |
700
-17,300
| -96% | -$363K | ﹤0.01% | 5378 |
|
|
2020
Q2 | $366K | Sell |
18,000
-31,300
| -63% | -$561K | ﹤0.01% | 2875 |
|
|
2020
Q1 | $510K | Sell |
49,300
-10,800
| -18% | -$302K | ﹤0.01% | 2036 |
|
|
2019
Q4 | $2.26M | Buy |
60,100
+55,200
| +1,127% | +$2.48M | 0.02% | 1197 |
|
|
2019
Q3 | $228K | Sell |
4,900
-1,800
| -27% | -$83.7K | ﹤0.01% | 2986 |
|
|
2019
Q2 | $350K | Buy |
+6,700
| New | +$393K | ﹤0.01% | 2456 |
|
|
2019
Q1 | – | Sell |
-2,700
| Closed | -$161K | – | 4859 |
|
|
2018
Q4 | $161K | Sell |
2,700
-2,100
| -44% | -$181K | ﹤0.01% | 2849 |
|
|
2018
Q3 | $556K | Buy |
4,800
+4,000
| +500% | +$451K | ﹤0.01% | 2189 |
|
|
2018
Q2 | $101K | Buy |
+800
| New | +$97.4K | ﹤0.01% | 3553 |
|
|
2018
Q1 | – | Sell |
-2,500
| Closed | -$274K | – | 4867 |
|
|
2017
Q4 | $274K | Buy |
+2,500
| New | +$250K | ﹤0.01% | 2712 |
|
|
2016
Q3 | – | Sell |
-2,400
| Closed | -$297K | – | 4571 |
|
|
2016
Q2 | $297K | Buy |
+2,400
| New | +$290K | ﹤0.01% | 2132 |
|
|
2016
Q1 | – | Sell |
-1,000
| Closed | -$109K | – | 4590 |
|
|
2015
Q4 | $109K | Buy |
+1,000
| New | +$114K | ﹤0.01% | 2921 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Group One Trading's CLB Position: Q1 2026 in Review
Group One Trading sold out of Core Laboratories (CLB) in Q1 2026, closing a stake of 52 shares — an estimated $834 sold.
Group One Trading first reported a position in CLB in Q4 2017 and held it in 14 quarters. The position peaked at $386K in Q4 2017. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Group One Trading reported no remaining Core Laboratories position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 52 Core Laboratories shares in Q1 2026, an estimated $834.
- Group One Trading first reported a position in Core Laboratories in Q4 2017 and held it in 14 quarters.
- Group One Trading's Core Laboratories position peaked at $386K in Q4 2017.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.